Introduction
Most if not all membrane functions are made possible by the unique composition of proteins and lipids in biological membranes. Although most biological membranes carry out similar functions, their composition varies largely (reviewed by Quinn, 1977) . Thus, the protein/lipid ratio of rat plasma membranes can vary from 0.25 in myelin to 1.5 in the liver. The ratio cholesterol/phospholipid can also vary from 1.0 in rat erythrocytes to 0.5 in rat liver plasma membranes. The phospholipid composition is also very variable; rat erythrocytes contain about 30% phosphatidylcholine but sheep erythrocytes contain only 5%. Variations in the phospholipid content are also found within a cell. Thus, the content of phosphatidylcholine of liver cell membranes varies from 61% in rough endoplasmic reticulum to 35% in plasma membranes, while the content of phosphatidylethanolamine is about 20% in all liver membrane fractions (McMurray & McGee, 1972) . It is important to remember these data when making generalizations. Another important feature of membranes is the rapid turnover of their phospholipids. The half-life of phosphatidylcholine in rat liver varies from 1 h to 1Oh depending on the type of precursor used (Tolbert & Okey, 1952; Arvidson, 1968) . Different cell fractions of rat liver have also different phospholipid turnover. Thus, the half-life of phosphatidylcholine in rat liver mitochondria and microsomes is 16 h and 8 h respectively (Bygrave, 1969) . The significance of this rapid turnover is not well understood, but may result from membrane repair mechanisms as well as from structural changes which may render cell membranes more sensitive to activation. In this Review we will deal with the control mechanisms of phosphatidylcholine synthesis by the CDP-choline and transmethylation pathways. The catabolism of phosphatidylcholine has been recently reviewed (Van den Bosch, 1980) . Abbreviations used: AdoMet, S-adenosyl-L-methionine; AdoHcy, S-adenosyl-L-homocysteine; deaza-SIBA, 5'-deoxy-5'-isobutylthio-3-deaza-adenosine; chlorophenylthioadenosine 3', 
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The synthesis of phosphatidylcholine can occur by two different pathways: by the CDP-choline pathway (Kennedy & Weiss, 1956;  Kennedy, 1962) and by the transmethylation pathway (Bremer et al., 1960; Bremer & Greenberg, 1961) . The CDPcholine pathway is the major pathway for the synthesis of this phospholipid and involves the transfer of phosphocholine from CDP-choline to diacylglycerol. The enzyme which catalyses this reaction is called phosphocholine transferase and in the rat liver is located in the microsomal fraction (Gibson et al., 1961; Wilgram & Kennedy, 1963) . The rate-limiting step in the synthesis of phosphatidylcholine by this pathway is the cellular content of CDP-choline (Infante & Kinsella, 1978; Schneider & Vance, 1978 ; Vance & Choy, 1979;  Pritchard . The synthesis of CDPcholine involves the phosphorylation of choline and its conversion to CDP-choline with CTP.
The transmethylation pathway consists of the addition of three methyl groups to the amino moiety of a phosphatidylethanolamine molecule via AdoMet, the methyl donor. The enzyme which catalyses this reaction is called phospholipid Nmethyltransferase and in the rat liver is mainly located in the microsomal fraction (Bjornstad & Bremer, 1966; Skurdal & Cornatzer, 1975; Yeselma &W Moore, 1978) . Phosphatidyl-N-methylethanolamine and phosphatidyl-N,N-dimethylethanolamine are the two intermediate products of this reaction.
The question has arisen as to whether the conversion of phosphatidylethanolamine to phosphatidylcholine is catalysed by one or two enzymes. In three studies using solubilized methyltransferase from rat liver microsomes the results indicate that a single enzyme catalyses the stepwise methylation of phosphatidylethanolamine to phosphatidylcholine (Rehbinder & Greenberg, 1965; Tanaka et al., 1979; Schneider & Vance, 1979) . Sastry et al. (1981) have concluded that in rat liver microsomes the conversion of phosphatidylethanolamine to phosphatidylcholine is catalysed by two different methyltransferases. The first enzyme incorporates the first methyl group and the second methyltransferase the remaining two methyl groups. This conclusion is mainly based on kinetic data showing non-linear kinetics when microsomes are incubated with different concentrations of labelled AdoMet. At low concentrations of AdoMet, phosphatidyl-Nmethylethanolamine is the main product of the transmethylation reaction, whereas at high concentrations of AdoMet phosphatidylN,N-dimethylethanolamine and phosphatidylcholine are synthesized. Phospholipid N-methyltransferase showing non-linear kinetics has been described in a number of cells and tissues, including bovine adrenal medulla (Hirata & Axelrod, 1978a) , rat brain synaptosomes (Crews et al., 1980a) and Dictyostelium discoideum (Garcia and in some cases this behaviour has been regarded as indicative of the existence of two methyltransferases. As mentioned by Vance et al. (1982) , these kinetic studies did not consider the converson of phosphatidyl-N-methylethanolamine to phosphatidyl-N,N-dimethylethanolamine during the enzyme assay. Since this reaction is relatively fast and the initial methylation of phosphatidylethanolamine to phosphatidyl-Nmethylethanolamine is relatively slow (Schneider & Vance, 1979) , this introduces an error in the determination of the kinetic parameters for the initial methylation reaction. The claims of two methyltransferases based only on kinetic data are therefore not justified. Another source of error in the determination of the kinetics of phospholipid Nmethyltransferase is the possible methylation of lipids other than phospholipids. Several neutral lipids are formed by incubation with AdoMet (Zatz et al., 1981; Alemany et al., 1982a) or by incubation of intact cells with methionine (Rabe & McGee, 1982) . Some of these lipids have been identified as methyl esters of fatty acids (Zatz et al., 1981) and as S-methyl-N-oleoyl-mercaptoethylamide (Zatz et al., 1982) .
Evidence indicating the presence of at least two phospholipid N-methyltransferases has been obtained with rat pituitary extracts (Prasad & Edwards, 1981a) . The supernatant fraction after 20min centrifugation at 20000g of pituitary extracts catalyses the transfer of the first methyl group into phosphatidylethanolamine, and the particulate fraction incorporates methyl groups into phosphatidyl-N-methylethanolamine, phosphatidyl-N,N-dimethylethanolamine and phosphatidylcholine. Although these results suggest the existence of two methyltransferases in rat pituitary extracts, it is possible that there is only one enzyme and that the substrate specificity changes depending on its particulate state. Evidence in favour of two phospholipid N-methyltransferases has also been obtained with RBL cells . At low concentrations of AdoMet, RBL cell extracts incorporate methyl groups preferentially into phosphatidyl-N-methylethanolamine and at high concentrations of substrate into phosphatidylcholine. RBL cell variants have been isolated which methylate phosphatidylethanolamine to phosphatidyl-Nmonomethylethanolamine but have an impaired transfer to phosphatidyl-N,N-dimethylethanolamine and phosphatidylcholine (20% of that of the parental line). Similarly, variants have been obtained which could methylate phosphatidyl-N-methylethanolamine or phosphatidyl-N,N-dimethylethanolamine to phosphatidylcholine but have an impaired transfer (18% of that of the parental line) to phosphatidyl-N-methylethanolamine. Reconstitution by fusion of the two RBL cell variants results in normal phospholipid N-methylation. These results are very suggestive of the presence of more than one phospholipid N-methyltransferase in RBL cells. However, none of the variants has exclusively one of the methyltransferase activities and the possibility that the differences in phospholipid N-methylation are due to other unknown defects cannot be excluded.
In conclusion, whether there is more than one enzyme that catalyses the three-step methylation of phosphatidylethanolamine to phosphatidylcholine is undecided and will have to await till the enzyme(s) is purified and its substrate specificity assayed.
Regulation of phospholipid N-methylation
During the last few years evidence has accumulated which indicates that several signals acting on cell-surface receptors regulate the methylation of phosphatidylethanolamine (Tables 1 and 2 ). With hepatocytes isolated from mature rats the addition of glucagon before homogenization produces a timeand dose-dependent activation. of the methylation reaction (Castanio et al., 1980) . The activation is about two-fold, occurs at physiological concentrations of glucagon and is due to an increase in the Vmaxu of the enzyme without affecting the apparent Km value for AdoMet. Cyclic AMP added exogenously to rat hepatocytes reproduces the effect of glucagon on phospholipid N-methylation (Castan-o et al., 1980) . The addition of isoprenaline to hepatocytes isolated from mature adrenalectomized rats, which contain a larger number of functional f-receptors, also stimulates the activity of phospholipid N-methyltransferase (D. Marin Cao, V. Alvarez Chiva & J. M. Mato, unpublished work) . This effect is dose-and time-dependent and is inhibited by the fl-blocker propranolol and by insulin. CPT-cAMP added exogenously to rat hepatocytes also stimulates phospholipid N-methyltransferase by about two-fold . Finally, the addition of cyclic AMP in the presence of micromolar concentrations of ATP to rat liver microsomes stimulates phospholipid Nmethyltransferase which suggests the involvement of a cyclic AMP-dependent (Geelen et al., 1979) or to have no effect on (Schanche et al., 1982) phospholipid N-methylation, and addition of CPTcAMP to rat hepatocytes has been shown to inhibit Vol. 213 phospholipid N-methylation . To ability of phosphatidylethanolamine as it accumulates in the hepatocyte after the inhibition of the N-methylation reaction. No evidence supporting this hypothesis was however given. Furthermore, the addition of exogenous phosphatidylethanolamine (2mg/ml) does not change the enzyme activity of homogenates from either control or glucagon-treated hepatocytes (Castafio et al., 1980) ; similarly, phosphatidylethanolamine added to rat liver microsomes does not stimulate methylation (Schneider & Vance, 1979) ; and the N-methylation of phosphatidylethanolamine to phosphatidylcholine in rat hepatocytes remains constant when the rate of phosphatidylethanolamine synthesis is varied up to 8-fold (Sundler & Akesson, 1975) . These results indicate that, as reported by Bremer (1969) , in hepatocytes isolated from normally fed rats the concentration of phosphatidylethanolamine is enough to saturate the methylation reaction. Under these conditions, a stimulation of the rate of phospholipid N-methylation could not be explained by an increase in the amount of phosphatidylethanolamine. In hepatocytes maintained in the absence of ethanolamine for 24h the amount of phosphatidylethanolamine decreases by about 30% (Akesson, 1978) . Under these conditions an increase in the concentration of phosphatidylethanolamine results in an increased rate of methylation until a plateau is reached (Akesson, 1978) . There is no evidence however that might indicate that a similar situation applies to the results of Pritchard et al. (1981) .
Another possibility to explain the results with CPT-cAMP is that in addition to its effect on phospholipid N-methyltransferase this compound may alter the metabolism of AdoMet. Although CPT-cAMP is more resistant than cyclic AMP to hydrolysis (Miller et al., 1975) , the incubation of hepatocytes for lh with 0.5mM-CPT-cAMP may result in intracellular accumulation of different adenosine derivatives. Adenosine and its derivatives are known to inhibit phospholipid N-methylation by affecting the ratio AdoMet/nucleosidylhomocysteine (Cantoni & Chiang, 1980; Hoffman et al., 1980; Garcia Castro et al., 1983 ). In conclusion, we believe that there is strong evidence indicating that the addition to rat hepatocytes of hormones that cause the accumulation of cyclic AMP stimulates phospholipid N-methylation.
Evidence in favour of a cyclic AMP-dependent mechanism of activation of phospholipid N-methyltransferase has also been obtained with rat Leydig cells (Nieto & Catt, 1983 In rat reticulocyte ghosts isoprenatine induces a dose-dependent stimulation of phospholipid Nmethyltransferase (Hirata et al., 1979a) . On the other hand, this effect is not reproduced by 8-bromo cyclic AMP, NaF or cholera toxin, These results indicate that the stimulation of phospholipid Nmethylation is mediated by the binding of isoprenaline to its receptor but not by cyclic AMP. In rat glioma cells isoprenaline stimulates the incorporation of radioactivity from [methyl-3Hlmeth-ionine into phospholipids (Munzel & Koschel, 1982) ; and in pineal glands of spontaneously hypertensive rats increased levels of adrenaline correlate with a stimulation of phospholipid N-methyltransferase (Saavedra, 1980) . Whether these fI-adrenergic effects are mediated by the interaction of hormone and receptor directly or by the cyclic AMP generated by the hormone is not known. Evidence indicating that the stimulation of phospholipid N-methyltransferase is mediated by the binding of a ligand to its receptor and not by the cyclic AMP formed has also been obtained in rat mast cells. Bridging of immunoglobulin E receptors to isolated plasma membranes from rat mast cells stimulates phospholipid Nmethyltransferase in the absence of cyclic AMP (Ishizaka et aL, 1981) . In rat hepatocytes, as mentioned earlier, phospholipid N-methyltransferase is mainly located in the microsomal fraction. Therefore, to activate phospholipid N-methylation a messenger that moves from the plasma membrane, where the interaction of ligand and receptor takes place, to the endoplasmic reticulum, is necessary. As mentioned above, there is evidence indicating that one of these messengers is cyclic AMP. In addition, there is also evidence that indicates that Ca2+ regulates phospholipid N-methyltransferase in rat hepatocytes.
In rat hepatocytes the addition of vasopressin or angiotensin, two hormones whose actions in this organ are mediated through Ca2+ (Fain, 1978; Kirk & Hems, 1974; Keppens & De Wulf, 1976) , induce a dose-and time-dependent activation of phospholipid N-methyltransferase (Alemany et al., 1981) . This effect is reproduced by the cationophore A23 187. In the absence of external Ca2+ none of the above hormones stimulate phospholipid N-methyltransferase. The addition of micromolar Ca2+ in the presence of ATP to rat liver microsomes also stimulates phospholipid N-methyltransferase (Alemany et al., 1982a) . Different lines of evidence indicate that calmodulin, a ubiquitous Ca2+-binding protein (reviewed by Cheung, 1982) , mediates the effect of Ca2+ on phospholipid N-methylation by isolated rat liver microsomes (Alemany et al., 1982a) . A similar mechanism seems to operate in extracts of Dictyostelium discoideum (Garcia . Vasopressin added to rat pituitary extracts also activates phospholipid N-methyltransferase (Prasad & Edwards, 198 ; immunoglobulin E in RBL cells (Crews et al., 1980b) and rat mast cells (Ishizaka et al., 1980) ; nerve growth factor in rat neuritis (Pfenninger & Johnson, 1981) ; corticotropin-releasing factor in mouse pituitary tumour cells (Hook et al., 1982) ; and agents that induce differentiation in chicken embryos (Zelenka et al., 1982) . The mechanisms by which these signals activate phospholipid N-methylation are not known. Hirata et al. (1979b [methy!-3Hlmethionine into phospholipids has been observed in rabbit leucocytes (Hirata et al., 1979b) and macrophages (Pike et al., 1979) in response to attractants. Whereas the data with rabbit leucocytes were interpreted as the result of an accelerated degradation, an inhibition of the rate of synthesis of methylated phospholipids was postulated to occur in macrophages. In none of these cases was the activity of phospholipid N-methyltransferase assayed following stimulation. In human platelets the addition of thrombin causes a fast decrease in phospholipid N-methylation (Shattil et al., 1981) . This effect seems to be due to a decreased synthesis of methylated lipids rather than to an increase in their degradation. Finally, the addition to human neutrophils of zymosan particles coated with complement also inhibits phospholipid N-methyltransferase and the incorporation of radioactivity from [methyl3Hlmethionine into phospholipids (Garcia Gil et al., 1981 ).
In conclusion, a variety of signals acting through cell surface receptors modulate phospholipid Nmethylation in several cells and tissues and the effect can be either an activation or an inhibition of the rate of transmethylation.
What is the function of phospholipid N-methylation?
Phosphatidylcholine synthesized in the liver is utilized in membrane formation within the organ or is transferred into bile or blood plasma lipoproteins (reviewed by Coleman, 1973) . Before considering the possible role of phospholipid N-methylation during these functions it is important to examine how the synthesis of phosphatidylcholine by the CDP-choline pathway is regulated in the liver.
As mentioned earlier in this Review the CDPcholine pathway is the major route for the synthesis of phosphatidylcholine. In isolated hepatocytes, treatment with CPT-cAMP or 8-bromo cyclic AMP decreases by about 40% the synthesis of phosphatidylcholine from [3Hlcholine . This effect seems to be due to an inhibition of phosphocholine cytidyltransferase , the enzyme that catalyses the synthesis of CDP-choline and the rate-limiting step in the synthesis of phosphatidylcholine by the CDP-choline pathway (Infante & Kinsella, 1978; Schneider & Vance, 1978; Vance & Choy, 1979; . Aminophylline, a cyclic AMP phosphodiesterase inhibitor, also inhibits [3H]choline incorporation into phosphatidylcholine in rat liver . Finally, recent results with rat liver cytosol indicate that a cyclic AMP-dependent protein kinase is involved in the regulation of phosphocholine cytidyltransferase . In all these experiments the hepatocytes were exposed to the cyclic AMP derivatives for up to 5 h. Prolonged treatment, up to 15 h, with cyclic AMP derivatives increases the rate of phosphatidylcholine synthesis by rat hepatocytes Vol. 213 . The mechanisms by which a prolonged treatment of rat hepatocytes with cyclic AMP derivatives stimulates phosphatidylcholine synthesis, thereby reversing the initial effect of these compounds, are not known. As in the liver, in the lung the synthesis of phosphatidylcholine by the CDP-choline pathway is stimulated after 12h treatment with aminophylline, 8-bromo cyclic AMP and dibutyryl cyclic AMP (Gross & Rooney, 1977; Niles & Makarski, 1979) . Results showing the initial effect of cyclic AMP on phosphatidylcholine synthesis by lung are not available.
The inhibitory effect in hepatocytes of an initial exposure to cyclic AMP on the biosynthesis of phosphatidylcholine by the CDP-choline pathway contrasts with the previously discussed stimulation of the transmethylation pathway by hormones that increase intracellular cyclic AMP levels. A similar behaviour seemp to occur in response to hormones that increase intracellular Ca2+ levels. We have mentioned earlier that in rat hepatocytes the addition of vasopressin and angiotensin before homogenization stimulates phospholipid N-methyltransferase. These two hormones and the cationophore A23187 also induce a rapid inhibition of the rate of incorporation of [3Hlcholine into phosphatidylcholine in rat hepatocytes (Alemany et al., 1982b) . Results with liver microsomes indicate that this effect is due, at least in part, to the inhibition of phosphocholine transferase by Ca2+ (Kennedy & Weiss, 1956; Alemany et al., 1982b) . Results from different laboratories indicate that cyclic AMP and Ca2+ also inhibit the formation of diacylglycerol (Soler-Argilaga et al., 1977; Sugden et al., 1980; Declerq et al., 1982) , one of the two substrates necessary for the synthesis of phosphatidylcholine by the CDP-choline pathway. These results indicate that cyclic AMP and Ca2+ inhibit the CDP-choline pathway by acting at various levels.
A plausible model showing the effects of Ca2+ and cyclic AMP on phosphatidylcholine synthesis by the CDP-choline and transmethylation pathways in the liver is shown in Fig. 1 . This model indicates that both pathways are regulated in a co-ordinated way and that an inhibition of the CDP-choline pathway is accompanied by a stimulation of the transmethylation route. In support of this co-ordinated mechanism of regulation of phosphatidylcholine synthesis are the following observations: the intraperitoneal injection of choline increases phosphocholine transferase and decreases phospholipid N-methyltransferase in rat liver microsomes (Skurdal & Cornatzer, 1975) ; choline deficiency increases. phospholipid N-methyltransferase and inhibits the CDPcholine pathway (Lombardi et al., '1969; Thompson et al., 1969; Schneider & Vance, 1978) , and the inhibition of the transmethylation pathway by intraperitoneal injection of 3-deaza-adenosine in rats is accompanied by a stimulation of the CDP-choline pathway . Since phospholipid N-methylation accounts for 20-40% of the total synthesis of phosphatidylcholine in rat liver (Sundler & Akesson, 1975) and since the turnover of this phospholipid in this organ is very rapid, with a half-life of 1-lOh (Tolbert & Okey, 1952; Arvidson, 1968) , we believe that the purpose of this co-ordinated mechanism is to maintain a steady state level of phosphatidylcholine synthesis under different metabolic conditions.
In other cells and tissues there is also evidence indicating a co-ordinated mechanism of regulation of phosphatidylcholine synthesis by the CDP-choline and transmethylation pathways. During viral transformation of hamster fibroblasts the transmethylation pathway increases (Maziere et al., 1981) and the CDP-choline pathway decreases (Maziere et al., 1982) . Differentiation of myeloid leukaemia cells is accompanied by a decrease in methylation of phospholipids and an increase in the CDP-choline pathway (Honma et al., 1981) . Antitubulins decrease phospholipid N-methylation and stimulate the CDP-choline pathway in phagocytes (Pike et al., 1980) . The addition to human neutrophils of zymosan particles coated with complement decreases phospholipid N-methyltransferase and stimulates the CDP-choline pathway (Garcia Gil et al., 1981 . Although more examples may appear showing that these two pathways are regulated in a co-ordinated way, there are also exceptions to this control mechanism. Thus, the addition of thrombin to platelets inhibits both the transmethylation and the CDP-choline pathway (Shattil et al., 1981) ; chemoattractants inhibit the incorporation of radioactivity from [3Hlmethionine into phospholipids in rabbit neutrophils (Hirata et al., 1979; Pike et al., 1979) , whereas the CDP-choline pathway remains constant (Hirata et al., 1979b) ; and treatment of rabbit neutrophils with inhibitors of receptor-mediated endocytosis inhibits both the transmethylation and CDP-choline pathways .
The purpose of a co-ordinated mechanism of regulation of phosphatidylcholine synthesis in cells and organs other than the liver is not to maintain a steady-state level of this lipid. This becomes clear when we consider that the activity of phospholipid N-methyltransferase in the liver is 10-1000-fold higher than in most, if not all, other cells and tissues and that in these systems the relative contribution of the transmethylation pathway to the total synthesis of phosphatidylcholine is negligible (see Vance & Kruijff, 1980 (Crews et al., 1980b; Ishizaka et al., 1980) . RBL cell variants have been isolated which are deficient in phospholipid N-methylation and immunoglobulin E-mediated, but not ionophore-mediated, histamine release . Reconstitution by hybridization of these variants results in normal phospholipid N-methylation and immunoglobulin E-mediated histamine release. These results indicate that phospholipid N-methylation is required for the initial activation in these cells.
To explore the functions of phospholipid Nmethylation one of the experimental approaches has been to study the effect of inhibitors of transmethylation on the behaviour of cells in response to Vol. 213 stimulation. 3-Deaza-adenosine and 5'-deoxy-5'-isobutylthio-3-deaza-adenosine (deaza-SIBA) are the two compounds most frequently used. 3-Deazaadenosine raises the cellular content of AdoHcy and 3-deaza-AdoHcy by inhibiting AdoHcy hydrolase; both these compounds are inhibitors of most if not all transmethylation reactions (Kerr, 1977; Chiang et al., 1977; Zimmerman et al., 1978; Chiang & Cantoni, 1979; Cantoni & Chiang, 1980) . Deaza-SIBA, an analogue of AdoHcy (Chiang et al., 1978) inhibits thymidine incorporation in response to concanavalin A in mouse lymphocytes and the release of histamine in response to immunoglobulin E in RBL cells (Crews et al., 1980b) and rat mast cells (Ishizaka et al., 1980) . However, in addition to inhibiting phospholipid N-methylation, deaza-SIBA is a potent inhibitor of the CDP-choline pathway for the synthesis of phosphatidylcholine in RBL cells (Morita et al., , 1981) , which invalidates the use of this compound to study the cellular functions regulated by phospholipid N-methylation. 3-Deazaadenosine inhibits phospholipid N-methylation and a number of cell functions, including immunoglobulin E-mediated histamine release (Crews et al., 1980b and rabbit neutrophil chemotaxis (Zimmerman et al., 1979; Bareis et al., 1982; Garcia Castro et al., 1983) . However, this compound increases cyclic AMP levels (Zimmerman et al., 1979 (Zimmerman et al., , 1980 which may account for some of its effects. This compound inhibits phospholipid N-methylation and chemotaxis in rabbit neutrophils (Bareis et al., 1982; Garcia Castro et al., 1983 ). However, adenosine, which also inhibits phospholipid N-methylation in rabbit neutrophils by drastically changing the ratio AdoMet/AdoHcy, has no effect on chemotaxis (Garcia Castro et al., 1983) . Furthermore, preincubation with adenosine protects rabbit neutrophils against the inhibitory effect of 3-deaza-adenosine on chemotaxis but not on phospholipid Nmethylation. None of these treatments has any effect on the CDP-choline pathway. These results indicate that phospholipid N-methylation is not primarily involved in neutrophil chemotaxis. Similarly, while 3-deaza-adenosine inhibits phospholipid N-methylation and potentiates platelet aggregation, 3-deazaaristeromycin, which is equipotent in inhibiting phospholipid N-methylation, has no effect on aggregation (Shattil et al., 1982) . This and other studies (Random et al., 1981; Hotchkiss et al., 1981; Lecompte et al., 1982) indicate that phospholipid N-methylation is not required for the initial activation of platelets. Finally, it should be remembered that 3-deaza-adenosine is also an inhibitor of methylation reactions other than those of phospholipids, which might account for some of its effects. To conclude, although 3-deaza-adenosine is a good tool to explore the functions of phospholipid N-methylation, caution should be exercised in interpreting the results obtained with this compound.
Phospholipid N-methylation has been reported to increase membrane fluidity in rat erythrocyte membranes (Hirata & Axelrod, 1978b) and rat reticulocyte ghosts (Hirata et al., 1979b) . These results have been criticized on the basis that methylation of very small amounts of phosphatidylethanolamine could not produce large changes in membrane fluidity (Vance & Kruijff, 1980) . Furthermore, neither phospholipid N-methylation nor the addition of phosphatidyl N-methylethanolamine produce large changes in membrane fluidity (Chauhan et al., 1982) . With LM cells alteration by more than 50% of the polar head group of the phospholipids had no effect on membrane fluidity (Schroeder et al., 1976) . We therefore conclude that there is no clear evidence linking phospholipid N-methylation and membrane fluidity.
Phospholipid N-methylation has also been related to adenylate cyclase activation by isoprenaline and immunoglobulin E in reticulocyte ghosts (Hirata et al., 1979a) and rat mast cells (Ishizaka et al., 1981) respectively. However, phospholipid Nmethylation has no effect on adenylate cyclase from rat liver plasma membranes (Colard & Breton, 1981) or cyclic AMP production by rat hepatocytes (Schanche et al., 1982) . These results indicate that at present it is difficult to make generalizations about the functions of phospholipid N-methylation. Another function attributed to phospholipid Nmethylation is the control of the number of cell surface receptors. Incubation with AdoMet increases the number of 16-adrenergic receptors in reticulocytes (Strittmatter et al., 1979) and of lactogenic receptors in mammary gland membranes (Bhattacharya & Vonderhaar, 1979) . The mechanism by which these changes may take place is not known.
Evidence indicating that phospholipid N-methylation provides phosphatidylcholine molecules rich in arachidonic acid has been obtained in platelets (Kannagi et al., 1980) and RBL cells . This led to the hypothesis that arachidonic acid is liberated during cellular activation from a pool of phosphatidylcholine that is synthesized by methylation of phosphatidylethanolamine (reviewed by . This hypothesis has been recently criticized (Irvine, 1982) . Here we should only mention that liberation of arachidonic acid during cellular activation has been observed both during stimulation (Crews et al., 1980b; Ishizaka et al., 1980) and inhibition (Shattil et al., 1981; Rittenhouse-Simmons, 1979; Garcia Gil et al., 1981 Pike & Snyderman, 1981) of phospholipid N-methylation. These results make it difficult to visualize a general mechanism linking phospholipid N-methylation to arachidonate liberation.
To summarize, although the data shown in Table 2 strongly suggest that in a variety of cells phospholipid N-methylation is involved in signal transduction, the biochemical or biophysical signals which might be triggered by changes in the rate of phospholipid N-methylation remain to be determined. In the liver, however, the present evidence indicates that this pathway is important in meeting the cellular requirements for phosphatidylcholine.
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